Explore how new heart failure drugs like SGLT2 inhibitors are revolutionizing treatment by changing cardiac metabolism and improving functional capacity.
Discover how heart failure actively sabotages muscle function through biochemical and structural changes in muscle fibers.
Exploring why adding urapidil to ACE inhibitors provides no benefit for chronic congestive heart failure patients, based on placebo-controlled clinical trial results.
Explore the fascinating battle between ACE Inhibitors and Sartans in treating heart failure, their mechanisms, and clinical evidence.